Assessing Axillary Lymph Node Burden and Prognosis in cT1‐T2 Stage Breast Cancer Using Machine Learning Methods: A Retrospective Dual‐Institutional MRI Study

医学 乳腺癌 淋巴结 比例危险模型 癌症 内科学 肿瘤科 机器学习 计算机科学
作者
Jiayi Liao,Zeyan Xu,Yu Xie,Yanting Liang,Qingru Hu,Chunling Liu,Lifen Yan,Wenjun Diao,Zaiyi Liu,Lei Wu,Changhong Liang
出处
期刊:Journal of Magnetic Resonance Imaging [Wiley]
卷期号:61 (3): 1221-1231 被引量:2
标识
DOI:10.1002/jmri.29554
摘要

Background Pathological axillary lymph node (pALN) burden is an important factor for treatment decision‐making in clinical T1‐T2 (cT1‐T2) stage breast cancer. Preoperative assessment of the pALN burden and prognosis aids in the individualized selection of therapeutic approaches. Purpose To develop and validate a machine learning (ML) model based on clinicopathological and MRI characteristics for assessing pALN burden and survival in patients with cT1‐T2 stage breast cancer. Study Type Retrospective. Population A total of 506 females (range: 24–83 years) with cT1‐T2 stage breast cancer from two institutions, forming the training ( N = 340), internal validation ( N = 85), and external validation cohorts ( N = 81), respectively. Field Strength/Sequence This study used 1.5‐T, axial fat‐suppressed T2‐weighted turbo spin‐echo sequence and axial three‐dimensional dynamic contrast‐enhanced fat‐suppressed T1‐weighted gradient echo sequence. Assessment Four ML methods (eXtreme Gradient Boosting [XGBoost], Support Vector Machine, k‐Nearest Neighbor, Classification and Regression Tree) were employed to develop models based on clinicopathological and MRI characteristics. The performance of these models was evaluated by their discriminative ability. The best‐performing model was further analyzed to establish interpretability and used to calculate the pALN score. The relationships between the pALN score and disease‐free survival (DFS) were examined. Statistical Tests Chi‐squared test, Fisher's exact test, univariable logistic regression, area under the curve (AUC), Delong test, net reclassification improvement, integrated discrimination improvement, Hosmer‐Lemeshow test, log‐rank, Cox regression analyses, and intraclass correlation coefficient were performed. A P ‐value <0.05 was considered statistically significant. Results The XGB II model, developed based on the XGBoost algorithm, outperformed the other models with AUCs of 0.805, 0.803, and 0.818 in the three cohorts. The Shapley additive explanation plot indicated that the top variable in the XGB II model was the Node Reporting and Data System score. In multivariable Cox regression analysis, the pALN score was significantly associated with DFS (hazard ratio: 4.013, 95% confidence interval: 1.059–15.207). Data Conclusion The XGB II model may allow to evaluate pALN burden and could provide prognostic information in cT1‐T2 stage breast cancer patients. Level of Evidence 3 Technical Efficacy Stage 2
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
绝望的老实人完成签到,获得积分10
刚刚
刚刚
1秒前
lululu完成签到 ,获得积分10
1秒前
等等来不及了完成签到,获得积分10
2秒前
爆米花的应助被头铁老常采纳,获得10
2秒前
3秒前
庾傀斗发布了新的文献求助10
4秒前
shenkekeshen发布了新的文献求助10
4秒前
庾傀斗发布了新的文献求助10
4秒前
蓝莓小蛋糕完成签到 ,获得积分10
4秒前
情怀的应助被董雪采纳,获得10
5秒前
Cecilia发布了新的文献求助10
5秒前
5秒前
6秒前
6秒前
小圆儿完成签到 ,获得积分10
6秒前
maershui发布了新的文献求助10
6秒前
秋风的应助被殷勤的紫槐采纳,获得200
7秒前
文静煜城完成签到 ,获得积分10
8秒前
光年以北发布了新的文献求助10
8秒前
yang发布了新的文献求助10
8秒前
科研通AI6.4的应助被Han采纳,获得10
8秒前
情怀的应助被zy采纳,获得10
9秒前
JamesPei的应助被干净夏天采纳,获得10
9秒前
9秒前
9秒前
乐乐的应助被humble采纳,获得10
10秒前
11秒前
JamesPei的应助被兰应华采纳,获得10
11秒前
高挑的雁芙完成签到,获得积分10
11秒前
11秒前
子木风完成签到 ,获得积分10
11秒前
12秒前
13秒前
呓语发布了新的文献求助10
13秒前
潇洒觅波完成签到,获得积分10
13秒前
艾因兹怀斯完成签到,获得积分10
13秒前
老迟到的初珍完成签到,获得积分10
14秒前
大模型的应助被光年以北采纳,获得10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186541
求助须知:如何正确求助?哪些是违规求助? 9574894
关于积分的说明 21838647
捐赠科研通 7784174
什么是DOI,文献DOI怎么找? 3434800
关于科研通互助平台的介绍 2559183
邀请新用户注册赠送积分活动 2481565